title: Hemophagocytic syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma; successful treatment with high-dose intravenous immunoglobulin.
authors.forename: M
authors.initials: M
authors.lastname: Ostronoff
authors.forename: F
authors.initials: F
authors.lastname: Ostronoff
authors.forename: M
authors.initials: M
authors.lastname: Coutinho
authors.forename: R
authors.initials: R
authors.lastname: Calixto
authors.forename: A P
authors.initials: AP
authors.lastname: Souto Maior
authors.forename: A
authors.initials: A
authors.lastname: Sucupira
authors.forename: R
authors.initials: R
authors.lastname: Florencio
authors.forename: C
authors.initials: C
authors.lastname: Tagliari
mesh_terms: D016207:Cytokines / Q000378:metabolism; D005260:Female; D006801:Humans; D007107:Immune System / Q000378:metabolism; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D051359:Lymphohistiocytosis, Hemophagocytic / Q000175:diagnosis / Q000209:etiology*; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000628:therapy*; D036102:Peripheral Blood Stem Cell Transplantation / Q000009:adverse effects*; D010587:Phagocytosis; D013997:Time Factors; D014182:Transplantation, Autologous / Q000009:adverse effects*; D016896:Treatment Outcome
chemical_list: D016207:Cytokines; D016756:Immunoglobulins, Intravenous